Blood test for a protein linked to colorectal cancer
Part of Cancer, Digestive system clinical trials.
This study measures a protein called endocan in the blood of people newly diagnosed with colorectal cancer and compares it with healthy people. The goal is to see if this protein can help doctors understand or detect colorectal cancer better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have just been diagnosed with colorectal cancer (confirmed by a biopsy).
- You have not yet had surgery, chemotherapy, or radiation for this cancer.
- You do not have other active infections, autoimmune diseases, liver or kidney disease, or are pregnant.
- You are able to give written consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is collecting blood samples to improve a test that looks for signs of colorectal cancer in the blood. It may help find cancer earlier or better understand how to detect it.
This research study uses a blood test to look for signs of colorectal cancer in people who have other types of cancer or digestive diseases. The goal is to see if the test can correctly tell the difference between colorectal cancer and other conditions.
This study looks at a blood “DNA” test to see if it can help monitor colorectal cancer after surgery. It may benefit you by improving how doctors track cancer during routine follow-up visits.
This study looks at metabolic biomarkers in blood and tumor tissue to help detect colorectal cancer earlier, predict outcomes, and monitor for recurrence. It includes both people newly diagnosed with colorectal cancer and healthy volunteers for comparison.
This study looks for early signs of colorectal cancer and ways to check if it comes back after treatment. It uses blood samples to find markers that could help doctors diagnose and monitor the disease more effectively.
This study is looking for a blood-based marker that might help diagnose colorectal cancer and show how it progresses. By participating, you could contribute to improving early detection for others.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.